Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
Clinical trial NCT03515538 · COMPLETED
Trial details
- NCT number
- NCT03515538
- Sponsor
- EpicentRx, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-12
- Primary completion
- 2019-10-22
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.